Isolation of a panel of ultra-potent human antibodies neutralizing SARS-CoV-2 and viral variants of concern
2021 · Cell Discovery · 34 citations
https://doi.org/10.1038/s41421-021-00340-8
S
Sergey V. Kulemzin
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
47
Papers
737
Citations
15
h-index
15
i10-index
Sergey V. Kulemzin is an academic researcher from Novosibirsk State University. The author has contributed to research in topics: CAR-T cell therapy research & Immune Cell Function and Interaction & SARS-CoV-2 and COVID-19 Research. The author has an h-index of 15, co-authored 40 publications.
ORCID: 0000-0002-4706-623XPapers by this author
worksFCRL6 receptor: Expression and associated proteins
2010 · Immunology Letters · 24 citations
https://doi.org/10.1016/j.imlet.2010.09.023
VH3-53/66-Class RBD-Specific Human Monoclonal Antibody iB20 Displays Cross-Neutralizing Activity against Emerging SARS-CoV-2 Lineages
2022 · Journal of Personalized Medicine · 7 citations
https://doi.org/10.3390/jpm12060895
A potent, broadly neutralizing human monoclonal antibody that efficiently protects hACE2-transgenic mice from infection with the Wuhan, BA.5, and XBB.1.5 SARS-CoV-2 variants
2024 · Frontiers in Immunology · 6 citations
https://doi.org/10.3389/fimmu.2024.1442160
The Activity of Human NK Cells Towards 3D Heterotypic Cellular Tumor Model of Breast Cancer
2025 · Cells · 2 citations
https://doi.org/10.3390/cells14141039
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat